EASL Studio Podcast: Rifaximin for Hepatic Encephalopathy: Balancacing Benefits and Risks in the Era of Antimicrobial Resistance
Échec de l'ajout au panier.
Veuillez réessayer plus tard
Échec de l'ajout à la liste d'envies.
Veuillez réessayer plus tard
Échec de la suppression de la liste d’envies.
Veuillez réessayer plus tard
Échec du suivi du balado
Ne plus suivre le balado a échoué
EASL Studio Podcast: Rifaximin for Hepatic Encephalopathy: Balancacing Benefits and Risks in the Era of Antimicrobial Resistance
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
For World Antimicrobial Awareness Week 2025 (“Act Now: Protect Our Present, Secure Our Future”), this EASL Studio explores the balance between rifaximin’s benefits in hepatic encephalopathy and the global challenge of antimicrobial resistance.
Moderator: Debbie Shawcross
Speakers: Rajiv Jalan, Vishal Patel, Jonel Trebicka
All EASL Studio Podcasts are available on EASL Campus.
Click here to see all EASL Video Podcasts on Apple Podcasts.
This EASL Studio is supported by Alfasigma and Norgine. EASL has received no input from Alfasigma or Norgine with regards to the content of this programme.
Pas encore de commentaire